Clinigen Group plc (CLIN.L) (LON:CLIN) Shares Gap Down to $757.00

Clinigen Group plc (CLIN.L) (LON:CLIN) shares gapped down prior to trading on Tuesday . The stock had previously closed at GBX 757 ($9.89), but opened at GBX 722.50 ($9.44). Clinigen Group plc (CLIN.L) shares last traded at GBX 744.50 ($9.73), with a volume of 310,229 shares.

The firm has a market capitalization of £966.13 million and a PE ratio of 71.23. The company has a current ratio of 1.54, a quick ratio of 1.24 and a debt-to-equity ratio of 102.11. The firm has a 50-day moving average of GBX 739.31 and a two-hundred day moving average of GBX 675.81.

The business also recently declared a dividend, which will be paid on Tuesday, April 13th. Investors of record on Thursday, March 18th will be issued a GBX 2.15 ($0.03) dividend. The ex-dividend date of this dividend is Thursday, March 18th. This represents a yield of 0.28%. Clinigen Group plc (CLIN.L)’s dividend payout ratio is currently 0.68%.

Clinigen Group plc (CLIN.L) Company Profile (LON:CLIN)

Clinigen Group plc operates as a pharmaceutical and services company in the United Kingdom, rest of Europe, the United States, South Africa, Australia, and internationally. It operates through three segments: Commercial Medicines, Unlicensed Medicines, and Clinical Services. The Commercial Medicines segment acquires and licenses commercial medicines and then revitalises them, as well as provides access to licensed and branded generic medicines.

Read More: Why do commodities matter?

Receive News & Ratings for Clinigen Group plc (CLIN.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clinigen Group plc (CLIN.L) and related companies with's FREE daily email newsletter.